Targeting the PI3K/AKT/GSK3b pathway in Parkinson's disease: a therapeutic plan - Evidence review

Narrative review in Parkinson's disease links reduced PI3K/AKT signaling and higher GSK-3β activity to neuronal survival, oxidative stress and inflammation.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-19
DOI
https://doi.org/10.5281/zenodo.24366839
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Targeting the PI3K/AKT/GSK3b pathway in Parkinson's disease: a therapeutic plan - Evidence review

Deborah Iodice
Zenodo (CERN European Organization for Nuclear Research)
Parkinson's Disease Mechanisms and Treatments
article

Targeting the PI3K/AKT/GSK3b pathway in Parkinson's disease: a therapeutic plan - Evidence review

Deborah Iodice
article en

Abstract

Narrative review in Parkinson's disease links reduced PI3K/AKT signaling and higher GSK-3β activity to neuronal survival, oxidative stress and inflammation.

Zenodo (CERN European Organization for Nuclear Research)
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon